Nicholas Keen

3PUBLICATIONS
17CO-AUTHORS
Molecular targetsMechanobiologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 16, 2022
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors.

Michael Rigby, Gavin Bennett, Liuhong Chen

|Nov 02, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonism.

Kristen Hurov, Johanna Lahdenranta, Punit Upadhyaya

|Jan 27, 2021
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist.

Punit Upadhyaya, Johanna Lahdenranta, Kristen Hurov

Pageof 1